Term
What variables do you need to determine ΔG |
|
Definition
Standard G, concentration of products, concentration of reactants |
|
|
Term
What is ΔG at equilibrium? |
|
Definition
0, so G standard = -RTLnKeq |
|
|
Term
Keq in terms of rate constants |
|
Definition
|
|
Term
The ________ the activation energy, the _________ the rate constant |
|
Definition
The higher the activation energy, the smaller the rate constant |
|
|
Term
|
Definition
structure of the intermediate is different from the reactant and the product |
|
|
Term
Michaelis-Menten Equation |
|
Definition
v = [Vmax * S]/ [ [S] + Km]
|
|
|
Term
|
Definition
V = V max = kcat [E]
Independent of substrate concentrations |
|
|
Term
|
Definition
kcat/Km
(example - triose phosphate isomerase) |
|
|
Term
|
Definition
Proline and glycine - proline has 5 membered ring
Glycine is highly flexible so you don't want it in helix |
|
|
Term
|
Definition
Will usually connect successive of strands of antiparallel B sheets
Typically involves 4 amino acids, usually proline and glycine - glycine has no side chain - little steric hindrance
H bond between 1st and 4th amino acid |
|
|
Term
|
Definition
Also called motifs
example) EF hand (helix loop helix found in calcium binding proteins) |
|
|
Term
Tertiary structure of a protein determined by |
|
Definition
Primary structure of protein
Will assume lowest energy structure |
|
|
Term
|
Definition
L form amino acids in mammals; D form in bacterial cell walls |
|
|
Term
Serine/Threonine/Tyrosine |
|
Definition
Sites for phosphorylation by kinases |
|
|
Term
|
Definition
CysTEINE is the amino acid - cystine is the oxidized form of two joined together (disulfide bond) |
|
|
Term
Polar positive charged amino acids |
|
Definition
Lysine, arginine, histidine |
|
|
Term
Midpoint of titration curve corresponds to |
|
Definition
pKa
Higher pKa ... weaker acid |
|
|
Term
|
Definition
Point at which 50% of sites of hemoglobin are occupide by oxygen |
|
|
Term
Circle of Life for Hemoglobin |
|
Definition
Taut --> Oxygen breaks hydrogen bonds --> Relaxed --> CO2/positive charge --> induce formation of interchain and intrachain salt bridges --> release of oxygen and back to taut
|
|
|
Term
|
Definition
First 6 weeks: zeta and epsilon genes are upregulated
6 weeks: lifelong expression of alpha and begin gamma
birth: beta and some delta |
|
|
Term
Rightward and leftward shift of hemoglobin curve |
|
Definition
Any major change that causes leftward shift - erythrocytosis
Any major change that causes rightward shift - anemia |
|
|
Term
|
Definition
Methemoglobinemia - Fe2+ altered to Fe3+ and is unable to bind oxygen
Any remaining normal hemoglobin has increased affinity - leftward shift |
|
|
Term
|
Definition
moderately severe hemolytic anemia
3 alpha chains defective |
|
|
Term
Regulation of ALAS I and ALAS II |
|
Definition
ALAS II (erythroid) - high iron stimulates mRNA translation
ALAS II (hepatic) - high heme will increase mRNA degradation
Low levels of PLP decrease ALAS activity |
|
|
Term
|
Definition
Requires zinc
Also called ALA dehydratase
Requires 2 molecules of ALA
Inhibited by lead |
|
|
Term
|
Definition
Most severe in urban areas
GI + neurobehavioral symptoms
Hypochromic microcytic anemia (less hemoglobin because less heme being made)
5 mcg/dl <
Most preventable environmental disease among children less than 6 years of age |
|
|
Term
Enzymes inhibited by lead |
|
Definition
Porphobilinogen synthase and ferrochelatase |
|
|
Term
Enzyme deficits prior to formation of tetrapyrrole (HMB - hydroxymethylbilane) |
|
Definition
Will see more nervous system effects like in AIP (ALA synthase, hydroxymethylbilane synthase)
HMB synthase enzyme activity reduced - nervous system pathology |
|
|
Term
If enzymatic block is later in pathway of heme synthesis |
|
Definition
More cutaneous effects/photosensitivity (itching/pruritis, blisters, scars) due to presence on non-metalloporphyrins |
|
|
Term
|
Definition
block in uroporphyrinogen decarboxylase
Most common porphyria
Decreased activity of uroporphyrinogen decarboxylase due to mutations in UROD
Photosensitivity and discolored urine (red to tea color, and pink under fluorescence) are seen |
|
|
Term
Unconjugated bilirubin toxicity |
|
Definition
Elevated levels may be toxic to neurological tissues; low levels might serve as an antioxidant |
|
|
Term
Excess production of bilirubin |
|
Definition
Hemolytic jaundice, increased unconjugated bilirubin, also more conjugated bilirubin in bile |
|
|
Term
Disturbance in conjugation of bilirubin |
|
Definition
|
|
Term
Inhibition of secretion of conjugated bile |
|
Definition
Increased conjugated bilirubin in liver and will leak into blood too -- hyperbilirubinemia |
|
|
Term
|
Definition
tetrameric DNA binding protein specificity for oriC - initial melting of short AT rich region, ATP required |
|
|
Term
|
Definition
further separates double stranded DNA
ATP will get hydrolyzed |
|
|
Term
|
Definition
Initiation of DNA replication
Primase activity
Synthesizes first 20 nucleotides
No proofreading |
|
|
Term
DNA Polymerase delta and epsilon |
|
Definition
Elongation (Chromosomal DNA replication), DNA repair, highly processive |
|
|
Term
|
Definition
Immediately after DNA synthesis
Mut S and Mut L join (Mut H does strand specificity by methylated sequences)
Mut H has endonuclease activity - nicks strand, and then exonuclease removes dNMPs
Resynthesis carried out by DNA polymerase |
|
|
Term
|
Definition
Acts at any cell cycle stage, not just after DNA replication
DNA glycosylase will cleave modified base - number of glycosylases
Removed by AP endonuclease and exonuclease
DNA polymerase beta fills in gap |
|
|
Term
|
Definition
Can repair almost all bulky lesions - large multiprotein complex scans DNA for distortions in DNA structure, rather than specific base change
Exinuclease will bind and cleave damaged DNA at both sides of the lesion |
|
|
Term
|
Definition
Nucleotide excision repair; mutations that inactivate NER, cause disease --> extreme photosensitivity, develop skin cancer, neuro abnormalities |
|
|
Term
|
Definition
Rare, autosomal recessive disorder by bad homologous recombination
Poor motor skills, poor balance (ataxia), immunodeficiency, acute sensitivity to ionizing radiation |
|
|
Term
|
Definition
late S phase and G2 (needs homologous chromosome) unlike NHEJ (any stage of cell cycle) |
|
|
Term
|
Definition
binds to b subunit of RNA polymerase - preventing chain extension
Used in TB treatment |
|
|
Term
|
Definition
Binds to DNA template, interfering with RNA pol movement
Occasionally used in cancer chemotherapy |
|
|
Term
|
Definition
tight complex with polymerase II -- inhibits mRNA synthesis |
|
|
Term
Eukaryotic general transcription factors |
|
Definition
TF2D: binds TATA box + other promoter elements
TF2F: brings RNA Pol II to promoter
TF2H: melts DNA and allows pol 2 to clear the promoter |
|
|
Term
|
Definition
|
|
Term
|
Definition
INhibits initiation of translation and misreading of mRNA |
|
|
Term
|
Definition
Interacts with prokaryotic small ribosomal subunit and inhibits binding of incoming amino acid to A site |
|
|
Term
|
Definition
Interacts with prokaryotic large ribosomal subunit to block exit tunnel and release of nascent polypeptide |
|
|
Term
To be targeted to lysosome, |
|
Definition
|
|